Lataa...
Targeting IDH1 as a pro-senescent therapy in high-grade serous ovarian cancer
Epithelial ovarian cancer (EOC) is the deadliest gynecological cancer. High-grade serous carcinoma (HGSC) is the most frequently diagnosed and lethal histosubtype of EOC. A significant proportion of HGSC patients relapse with chemoresistant disease. Therefore, there is an urgent need for novel thera...
Tallennettuna:
| Julkaisussa: | Mol Cancer Res |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6679739/ https://ncbi.nlm.nih.gov/pubmed/31110157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-18-1233 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|